Page last updated: 2024-09-05

lu 135252 and Cardiomyopathies, Primary

lu 135252 has been researched along with Cardiomyopathies, Primary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dai, DZ; Dai, Y; Xia, HJ	1

Other Studies

1 other study(ies) available for lu 135252 and Cardiomyopathies, Primary

Article	Year
Up-regulated inflammatory factors endothelin, NFkappaB, TNFalpha and iNOS involved in exaggerated cardiac arrhythmias in l-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats. Life sciences, 2006, Oct-04, Volume: 79, Issue:19 Topics: Animals; Cardiomyopathies; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelins; Intercellular Signaling Peptides and Proteins; Male; NF-kappa B; Nitric Oxide Synthase Type II; Oxidation-Reduction; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Thyroxine; Tumor Necrosis Factor-alpha; Up-Regulation; Ventricular Fibrillation	2006

Article

Year

Up-regulated inflammatory factors endothelin, NFkappaB, TNFalpha and iNOS involved in exaggerated cardiac arrhythmias in l-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats.

Life sciences, 2006, Oct-04, Volume: 79, Issue:19

Topics: Animals; Cardiomyopathies; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelins; Intercellular Signaling Peptides and Proteins; Male; NF-kappa B; Nitric Oxide Synthase Type II; Oxidation-Reduction; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Thyroxine; Tumor Necrosis Factor-alpha; Up-Regulation; Ventricular Fibrillation

2006